tiprankstipranks
Oxford BioMedica plc (OXBDF)
OTHER OTC:OXBDF
US Market

Oxford BioMedica (OXBDF) Income Statement

Compare
61 Followers

Oxford BioMedica Income Statement

Last quarter (Q2 2024), Oxford BioMedica's total revenue was £50.81M, a decrease of -20.65% from the same quarter last year. In Q2, Oxford BioMedica's net income was £-32.48M. See Oxford BioMedica’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 89.54M£ 139.99M£ 142.80M£ 87.73M£ 64.06M
Gross Profit
£ 39.73M£ 69.18M£ 82.64M£ 46.07M£ 28.34M
Operating Expenses
£ 223.90M£ 120.74M£ 61.71M£ 50.94M£ 40.92M
Depreciation and Amortization
£ 28.71M£ 26.43M£ 12.46M£ 9.62M£ 5.79M
EBITDA
£ -148.62M£ -10.86M£ 33.22M£ 3.92M£ -9.60M
Operating Income
£ -184.17M£ -51.56M£ 20.77M£ -4.83M£ -12.58M
Other Income/Expenses
£ -4.35M£ -15.76M£ -888.00K£ -878.00K£ -6.42M
Pretax Income
£ -188.53M£ -45.98M£ 19.88M£ -6.57M£ -20.89M
Net Income
£ -157.49M£ -45.16M£ 19.01M£ -6.25M£ -16.07M
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -1.63£ -0.48£ 0.23£ -0.08£ -0.22
Diluted EPS
£ -1.63£ -0.48£ 0.22£ -0.08£ -0.22
Weighted Average Shares Outstanding
96.56M 94.83M 83.48M 79.94M 72.71M
Weighted Average Shares Outstanding (Diluted)
96.56M 94.83M 85.62M 79.94M 72.71M
Currency in GBP

Oxford BioMedica Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis